{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:42:48Z","timestamp":1778056968434,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijantimicag.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T12:20:28Z","timestamp":1461932428000},"page":"478-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Levofloxacin at the usual dosage to treat bone and joint infections: a cohort analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"N.","family":"Asseray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bourigault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Touchais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-8111","authenticated-orcid":false,"given":"S.","family":"Corvec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4448-3879","authenticated-orcid":false,"given":"D.","family":"Navas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.medmal.2009.05.004","article-title":"Clinical practice recommendations. Osteoarticular infections on materials (prosthesis, implants, osteosynthesis)","volume":"39","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPLIF) [French Society of Infectious Diseases]","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infections: clinical practice guidelines by the Infectious Diseases Society of America (IDSA)","volume":"56","author":"Osmon","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1097\/BRS.0b013e31816f6c22","article-title":"Fluoroquinolones versus \u03b2-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials","volume":"33","author":"Karamanis","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/39.2.241","article-title":"Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up","volume":"39","author":"Galanakis","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/48.6.927","article-title":"Rifampicin\u2013ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis","volume":"48","author":"Senneville","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1179\/joc.2007.19.6.682","article-title":"Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty","volume":"19","author":"Metallidis","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/dkh110","article-title":"Diffusion of levofloxacin into bone and synovial tissue","volume":"53","author":"Rimmel\u00e9","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199732020-00002","article-title":"The clinical pharmacokinetics of levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/48.2.253","article-title":"Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits","volume":"48","author":"Shirtliff","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/AAC.01163-08","article-title":"Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus","volume":"53","author":"Muller-Serieys","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1469-0691.2006.01523.x","article-title":"Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime\u2013fluoroquinolone combination","volume":"12","author":"Legout","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.44.1.164-166.2000","article-title":"Ciprofloxacin, lomefloxacin or levofloxacin as treatment for chronic osteomyelitis","volume":"44","author":"Greenberg","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.medmal.2012.07.018","article-title":"Pharmacokinetic and pharmacodynamic study of levofloxacin and rifampin in bone and joint infections","volume":"42","author":"Guillaume","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1179\/joc.2007.19.6.688","article-title":"Safety of prolonged high-dose levofloxacin therapy for bone infections","volume":"19","author":"Senneville","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10096-015-2404-z","article-title":"Influence of daily dosage and frequency of administration of rifampicin\u2013levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections","volume":"34","author":"Nguyen","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916300498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916300498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T19:24:57Z","timestamp":1536780297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916300498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0924857916300498"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.03.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levofloxacin at the usual dosage to treat bone and joint infections: a cohort analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}